awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34447778-52EDADA0-3C4A-4C45-B2C7-28A077321087
Q34447778-52EDADA0-3C4A-4C45-B2C7-28A077321087
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34447778-52EDADA0-3C4A-4C45-B2C7-28A077321087
Patient-derived models of acquired resistance can identify effective drug combinations for cancer.
P2860
Q34447778-52EDADA0-3C4A-4C45-B2C7-28A077321087
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34447778-52EDADA0-3C4A-4C45-B2C7-28A077321087
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
725b3d8e4f0967bb56fee35732210aa1eb4fe09d
P2860
N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor.